A one health approach to vaccines against Toxoplasma gondii

Ajzenberg, 2002, Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings, J. Infect. Dis., 186, 684, 10.1086/342663 Almeida, 2011, Aspectos sociopolíticos da epidemia de toxoplasmose em Santa Isabel do Ivaí (PR), Cien. Saude Colet., 16, 1363, 10.1590/S1413-81232011000700071 Arenas, 2010, Modeling toxoplasmosis spread in cat populations under vaccination, Theor. Popul. Biol., 77, 227, 10.1016/j.tpb.2010.03.005 Batz, 2012, Ranking the disease burden of 14 pathogens in food sources in the United States using attributation data from outbreak investigations and expert elicitation, J. Food Prot., 75, 1278, 10.4315/0362-028X.JFP-11-418 Beverley, 1971, Trial of a killed vaccine in the prevention of ovine abortion due to toxoplasmosis, Br. Vet. J., 127, 529, 10.1016/S0007-1935(17)37286-X Bissati, 2016, Adjuvanted mulita-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii, JCI Insight, 1, 10.1172/jci.insight.85955 Blewett, 1987, The epidemiology of ovine toxoplasmosis with especial respect to control, Br. Vet. J., 143, 128, 10.1016/0007-1935(87)90004-2 Boothroyd, 2009, Toxoplasma gondii: 25 years and 25 major advances for the field, Int. J. Parasitol., 39, 935, 10.1016/j.ijpara.2009.02.003 Braun, 2008, Purification of Toxoplasma dense granule proteins reveals that they are in complexes throughout the secretory pathway, Mol. Biochem. Parasitol., 157, 13, 10.1016/j.molbiopara.2007.09.002 Brown, 2018, Essential cGMP signaling in Toxoplasma is initiated by a hybrid P-type ATPase-guanylate cyclase, Cell Host Microbe, 24, 804, 10.1016/j.chom.2018.10.015 Brown, 2017, Plasma membrane association by N-acylation governs PKG function in Toxoplasma gondii, MBio, 8, 10.1128/mBio.00375-17 Brown, 2018, Conditional knockdown of proteins using auxin-inducible degron (AID) fusions in Toxoplasma gondii, Bio-protocol, 8, 10.21769/BioProtoc.2728 Burrells, 2015, Vaccination of pigs with the S48 strain of Toxoplasma gondii—safer meat for human consumption, Vet. Res., 46, 10.1186/s13567-015-0177-0 Burrells, 2018, Detection and dissemination of Toxoplasma gondii in experimentally infected calves, a single test does not tell the whole story, Parasit. Vectors, 11, 45, 10.1186/s13071-018-2632-z Buxton, 1993, Toxoplasmosis: the first commercial vaccine, Parasitol. Today, 9, 335, 10.1016/0169-4758(93)90236-9 Buxton, 1986, Experimental infection of pregnant sheep with Toxoplasma gondii: pathological and immunological observations on the placenta and foetus, J. Comp. Pathol., 96, 319, 10.1016/0021-9975(86)90052-6 Buxton, 1995, A commercial vaccine for ovine toxoplasmosis, Parasitology, 110, S11, 10.1017/S003118200000144X Buxton, 2008, Toxoplasmosis and neosporosis, 112 Buxton, 1989, Trial of a novel experimental toxoplasma ISCOM vaccine in pregnant sheep, Br. Vet. J., 145, 451, 10.1016/0007-1935(89)90053-5 Buxton, 1993, Experimental challenge of sheep 18 months after vaccination with a live (S48) Toxoplasma gondii vaccine, Vet. Rec., 133, 310, 10.1136/vr.133.13.310 Carme, 2002, Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana, J. Clin. Microbiol., 40, 4037, 10.1128/JCM.40.11.4037-4044.2002 Carme, 2009, Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana, Emerg. Infect. Dis., 15, 656, 10.3201/eid1504.081306 Carruthers, 2002, Host cell invasion by the opportunistic pathogen Toxoplasma gondii, Acta Trop., 81, 111, 10.1016/S0001-706X(01)00201-7 Chaichan, 2017, Geographical distribution of Toxoplasma gondii genotypes in Asia: a link with neighboring continents, Infect. Genet. Evol., 53, 227, 10.1016/j.meegid.2017.06.002 Chen, 2011, Genotyping of Toxoplasma gondii isolates from cats in different geographic regions of China, Vet. Parasitol., 183, 166, 10.1016/j.vetpar.2011.06.013 Chiang, 2014, Risk factors for acute Toxoplasma gondii diseases in Taiwan: a population-based case-control study, PLoS One, 9, 1, 10.1371/journal.pone.0090880 Choromanski, 1995, Safety and efficacy of modified live feline Toxoplasma gondii vaccine, Dev. Biol. Stand., 84, 269 Cong, 2010, Immunome Res., 6, 12, 10.1186/1745-7580-6-12 Cong, 2011, Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201, Vaccine, 29, 754, 10.1016/j.vaccine.2010.11.015 Cook, 2000, Sources of toxoplasma infection in pregnant women: European multicentre case-control study. Commentary: congenital toxoplasmosis, further food for thought, BMJ, 321, 142, 10.1136/bmj.321.7254.142 Cornelissen, 2014, An experimental Toxoplasma gondii dose response challenge model to study therapeutic or vaccine efficacy in cats, PLoS One, 9, 10.1371/journal.pone.0104740 Correa, 2007, Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host, Parasite Immunol., 29, 651, 10.1111/j.1365-3024.2007.00982.x Costa, 2018, Kinetics of parasite distribution after reinfection with genetically distinct strains of Toxoplasma gondii, Exp. Parasitol., 184, 22, 10.1016/j.exppara.2017.11.003 da Cunha, 2012, Humoral and cellular immune responses in pigs immunized intranasally with crude rhoptry proteins of toxoplasma gondii plus Quil-A, Vet. Parasitol., 186, 216, 10.1016/j.vetpar.2011.11.034 Davis, 1995, Mediation of immunity to Toxoplasma gondii oocyst shedding in cats, J. Parasitol., 81, 882, 10.2307/3284034 de Moura, 2006, Waterborne toxoplasmosis, Brazil, from field to gene, Emerg. Infect. Dis., 12, 326, 10.3201/eid1202.041115 De Sousa, 1997, In vivo microbial stimulation induces rapid CD40 ligand–independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas, J. Exp. Med., 186, 1819, 10.1084/jem.186.11.1819 de-la-Torre, 2013, Severe South American ocular toxoplasmosis is associated with decreased Ifn-gamma/Il-17a and increased Il-6/Il-13 intraocular levels, PLoS Negl. Trop. Dis., 7, 10.1371/journal.pntd.0002541 Delhaes, 2010, Severe congenital toxoplasmosis due to a Toxoplasma gondii strain with an atypical genotype: case report and review, Prenat. Diagn., 30, 902, 10.1002/pd.2563 Demar, 2007, Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects, Clin. Infect. Dis., 45, e88, 10.1086/521246 Di Cristina, 2018, New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites, Parasitology, 1 Dubey, 1983, Distribution of cysts and tachyzoites in calves and pregnant cows inoculated with Toxoplasma gondii oocysts, Vet. Parasitol., 13, 199, 10.1016/0304-4017(83)90057-2 Dubey, 1995, Duration of immunity to shedding of Toxoplasma gondii oocysts by cats, J. Parasitol., 81, 410, 10.2307/3283823 Dubey, 1996, Strategies to reduce transmission of Toxoplasma gondii to animals and humans, Vet. Parasitol., 64, 65, 10.1016/0304-4017(96)00961-2 Dubey, 2006, Comparative infectivity of oocysts and bradyzoites of Toxoplasma gondii for intermediate (mice) and definitive (cats) hosts, Vet. Parasitol., 140, 69, 10.1016/j.vetpar.2006.03.018 Dubey, 2010 Dubey, 1974, Immunity to feline toxoplasmosis: modification by administration of corticosteroids, Vet. Pathol., 11, 350, 10.1177/030098587401100407 Dubey, 1991, Protective immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii, Am. J. Vet. Res., 52, 1316 Dubey, 2008, High prevalence and abundant atypical genotypes of Toxoplasma gondii isolated from lambs destined for human consumption in the USA, Int. J. Parasitol., 38, 999, 10.1016/j.ijpara.2007.11.012 Dubey, 2011, High prevalence and genotypes of Toxoplasma gondii isolated from goats, from a retail meat store, destined for human consumption in the USA, Int. J. Parasitol., 41, 827, 10.1016/j.ijpara.2011.03.006 Dubey, 2012, Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease and epidemiology, Parasitology, 139, 1375, 10.1017/S0031182012000765 Dupont, 2012, Immune response and immunopathology during toxoplasmosis, Semin. Immunopathol., 34, 793, 10.1007/s00281-012-0339-3 Edwards, 2013, Toxoplasma gondii abortion storm in sheep on a Texas farm and isolation of mouse virulent atypical genotype T. gondii from an aborted lamb from a chronically infected ewe, Vet. Parasitol., 192, 129, 10.1016/j.vetpar.2012.09.037 EFSA, European Food Safety Authority, 2007, Scientific opinion of the panel on biological hazards on a request from EFSA on surveillance and monitoring of toxoplasma in humans, foods and animals, EFSA J., 583, 1 EFSA, European Food Safety Authority, 2018, Scientific opinion of the panel on biological hazards on a request from EFSA on public health risks associated with food-borne parasites, EFSA J., 16, 5495 (a) Elbez-Rubinstein, A., Ajzenberg, D., Darde, M. L., Cohen, R., Dumetre, A., Yera, H., Gondon, E., Janaud, J. C. and Thulliez, P., 2009. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J. Infect. Dis., 199, 280-285. Etheridge, 2014, The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice, Cell Host Microbe, 15, 537, 10.1016/j.chom.2014.04.002 Ferguson, 1987, An ultrastructural study of the early development and tissue cysts formation of Toxoplasma gondii in the brains of mice, Parasitol. Res., 73, 483, 10.1007/BF00535321 Filisetti, 2004, Immune response to Toxoplasma gondii, Ann. Ist. Super. Sanita, 40, 71 Freire, 2003, Vaccination of pigs with Toxoplasma gondii antigens incorporated in immunostimulating complexes (iscoms), Arq. Bras. Med. Veterinária e Zootec., 55, 388, 10.1590/S0102-09352003000400002 Frenkel, 2000, Biology of toxoplasma gondii, 9 Frenkel, 1991, Prospective vaccine prepared from a new mutant of Toxoplasma gondii for use in cats, Am. J. Vet. Res., 52, 759 Freyre, 1993, Immunization of cats with tissue cysts, Bradyzoites, and Tachyzoites of the T-263 strain of Toxoplasma gondii, J. Parasitol., 79, 716, 10.2307/3283610 Freyre, 2007, vol. 115, 48 Galal, 2018, Toxoplasma and Africa: one parasite, two opposite population structures, Trends Parasitol., 34, 140, 10.1016/j.pt.2017.10.010 Garcia, 2009, Vaccination concepts against Toxoplasma gondii, Expert Rev. Vaccines, 8, 215, 10.1586/14760584.8.2.215 Garcia, 2005, Partial protection against tissue cysts formation in pigs vaccinated with crude rhoptry proteins of Toxoplasma gondii, Vet. Parasitol., 129, 209, 10.1016/j.vetpar.2005.01.006 Garcia, 2007, Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route, Vet. Parasitol., 145, 197, 10.1016/j.vetpar.2007.01.007 Gazzinelli, 1993, Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts, Proc. Natl. Acad. Sci., 90, 6115, 10.1073/pnas.90.13.6115 Gazzinelli, 1994, Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii, J. Immunol., 153, 2533, 10.4049/jimmunol.153.6.2533 Gazzinelli, 2014, Innate resistance against Toxoplasma gondii: an evolutionary tale of mice, cats, and men, Cell Host Microbe, 15, 132, 10.1016/j.chom.2014.01.004 Gilbert, 2008, Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe, PLoS Negl. Trop. Dis., 2, e277, 10.1371/journal.pntd.0000277 Glasner, 1992, An unusually high prevalence of ocular toxoplasmosis in southern Brazil, Am J. Ophthalmol., 114, 136, 10.1016/S0002-9394(14)73976-5 Gräslund, 2008, Protein production and purification, Nat. Methods, 5, 135, 10.1038/nmeth.f.202 Guerra, 2018, Structural basis of Toxoplasma gondii perforin-like protein 1 membrane interaction and activity during egress, PLoS Pathog., 14, 10.1371/journal.ppat.1007476 Havelaar, 2015, World Health Organisation global estimates and regional comparisons of the burden of food borne disease in 2010, PLoS Med., 12, 10.1371/journal.pmed.1001923 Henriquez, 2010, Immunogenetics of Toxoplasma gondii informs vaccine design, Trends Parasitol., 26, 550, 10.1016/j.pt.2010.06.004 Hermentin, 1988, Efforts towards a vaccine against Toxoplasma gondii: a review, Zentralbl. Bakteriol. Mikrobiol. Hyg. - Abt. 1 Orig. A, 269, 423 Hiszcynska-Sawicka, 2011, Evaluation of immune responses in sheep induced by DNA immunisation with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii, Vet. Parasitol., 177, 281, 10.1016/j.vetpar.2010.11.047 Holland, 2003, Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease, Am J. Ophthalmol., 136, 973, 10.1016/j.ajo.2003.09.040 Howe, 1995, Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease, J. Infect. Dis., 172, 1561, 10.1093/infdis/172.6.1561 Hunter, 2012, Modulation of innate immunity by Toxoplasma gondii virulence effectors, Nat. Rev. Microbiol., 10, 766, 10.1038/nrmicro2858 Hunter, 1994, Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha, Infect. Immun., 62, 2818, 10.1128/IAI.62.7.2818-2824.1994 Huynh, 2009, Tagging of endogenous genes in a Toxoplasma gondii strain lacking Ku80, Eukaryot. Cell, 8, 530, 10.1128/EC.00358-08 Innes, 1997, Toxoplasmosis: comparative species susceptibility and host immune response, Comp. Immunol. Microbiol. Infect. Dis., 20, 131, 10.1016/S0147-9571(96)00038-0 Innes, 2006, Vaccination as a control strategyagainst the coccidial parasites Eimeria, Toxoplasma and Neospora, Parasitol, 133, 145, 10.1017/S0031182006001855 Innes, 1995, Analysis of in vivo immune responses during Toxoplasma gondii infection using the technique of lymphatic cannulation, Parasitol. Today, 11, 268, 10.1016/0169-4758(95)80210-X Innes, 1995, Induction of CD4+ and CD8+ T cell responses in efferent lymph responding to Toxoplasma gondii infection: analysis of phenotype and function, Parasite Immunol., 17, 151, 10.1111/j.1365-3024.1995.tb01017.x Innes, 2009, Veterinary vaccines against Toxoplasma gondii, Mem. Inst. Oswaldo Cruz, 104, 246, 10.1590/S0074-02762009000200018 Innes, 2011, Developing vaccines to control protozoan parasites in ruminants: dead or alive?, Vet. Parasitol., 180, 155, 10.1016/j.vetpar.2011.05.036 Jacquemard, 2000, Clinical aspects of infection during pregnancy, 111 Jensen, 2015, Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination, MBio, 6, 10.1128/mBio.02280-14 Jiang, 2012, An agent-based model for the transmission dynamics of Toxoplasma gondii, J. Theor. Biol., 293, 15, 10.1016/j.jtbi.2011.10.006 Jongert, 2008, An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-toxoplasma immune responses in pigs, Vaccine, 26, 1025, 10.1016/j.vaccine.2007.11.058 Jongert, 2009, Vaccines against Toxoplasma gondii: challenges and opportunities, Mem. Inst. Oswaldo Cruz, 104, 252, 10.1590/S0074-02762009000200019 Katzer, 2014, Immunisation of lambs with the S48 strain of Toxoplasma gondii reduces tissue cyst burden following oral challenge with a complete strain of the parasite, Vet. Parasitol., 15, 46, 10.1016/j.vetpar.2014.07.003 Khan, 2007, Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome, Proc. Natl. Acad. Sci. U. S. A., 104, 14872, 10.1073/pnas.0702356104 Khan, 2011, Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America, Int. J. Parasitol., 41, 645, 10.1016/j.ijpara.2011.01.005 Kijlstra, 2004, Toxoplasma gondii infection in animal friendly pig production systems, Invest. Ophthalmol. Vis. Sci., 45, 3165, 10.1167/iovs.04-0326 Koblansky, 2013, Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii, Immunity, 38, 119, 10.1016/j.immuni.2012.09.016 Kringel, 2004, CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii, Vet. Parasitol., 123, 55, 10.1016/j.vetpar.2004.01.021 Krishnamurthy, 2018, Toxoplasma does not secrete the GRA16 and GRA24 effectors beyond the parasitophorous vacuole membrane of tissue cysts, Front. Cell. Infect. Microbiol., 8, 366, 10.3389/fcimb.2018.00366 Lehmann, 2006, Globalization and the population structure of Toxoplasma gondii, Proc. Natl. Acad. Sci. U. S. A., 103, 11423, 10.1073/pnas.0601438103 Lelu, 2012, Quantitative estimation of the viability of Toxoplasma gondii oocysts in soil, Appl. Environ. Microbiol., 78, 5127, 10.1128/AEM.00246-12 Levy-Bruhl, 2009, The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey, Eur. J. Cancer, 45, 2709, 10.1016/j.ejca.2009.07.023 Luft, 1984, Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome, JAMA, 252, 913, 10.1001/jama.1984.03350070031018 Mateus-Pinilla, 1999, A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine, J. Parasitol., 85, 855, 10.2307/3285821 Mateus-Pinilla, 2002, A computer simulation of the prevention of the transmission of Toxoplasma gondii on swine farms using a feline T. gondii vaccine, Prev. Vet. Med., 55, 17, 10.1016/S0167-5877(02)00057-0 McAuley, 2014, Congenital toxoplasmosis, J. Pediatric. Infect. Dis. Soc., 30, 10.1093/jpids/piu077 McColgan, 1988, Titration of Toxoplasma gondii oocysts in non-pregnant sheep and the effects of subsequent challenge during pregnancy, Vet. Rec., 123, 467, 10.1136/vr.123.18.467 McLeod, 2012, Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981–2009), Clin. Infect. Dis., 54, 1595, 10.1093/cid/cis258 Meissner, 2001, Modulation of myosin A expression by a newly established tetracycline repressor-based inducible system in Toxoplasma gondii, Nucleic Acids Res., 29, e115, 10.1093/nar/29.22.e115 Melo, 2011, Toxoplasma gondii effectors are master regulators of the inflammatory response, Trends Parasitol., 27, 487, 10.1016/j.pt.2011.08.001 Mercier, 2010, Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon, PLoS Negl. Trop. Dis., 4, e876, 10.1371/journal.pntd.0000876 Mevelec, 2010, Mic1-3 knockouit Toxoplasma gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheep, Vet. Res., 41, 41, 10.1051/vetres/2010021 Mims, 1982 Mishima, 2002, Feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats, Parasitol. Res., 88, 144, 10.1007/s004360100429 Muller, 2017, Development of a murine vertical transmission model for Toxoplasma gondii oocysts infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis, J. Antimicrob. Chemother., 72, 2334, 10.1093/jac/dkx134 Murray, 2010, Number and ownership profiles of cats and dogs in the UK, Vet. Rec., 166, 163, 10.1136/vr.b4712 Nathan, 1983, Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity, J. Exp. Med., 158, 670, 10.1084/jem.158.3.670 Nicolle, 1908, Sur une infection a corps de Leishman (ou organismes voisins) du gondi, C. R. Seances Acad. Sci., 147, 763 Niedelman, 2012, The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response, PLoS Pathog., 8, 10.1371/journal.ppat.1002784 O'Connell, 1988, Toxoplasmosis in sheep. II. The ability of a live vaccine to prevent lamb losses after an intravenous challenge with Toxoplasma gondii, N. Z. Vet. J., 36, 1, 10.1080/00480169.1988.35461 Omata, 1996, Toxoplasma gondii: experimental infection in cats vaccinated with 60Co-irradiated tachyzoites, Vet. Parasitol., 65, 173, 10.1016/S0304-4017(96)00973-9 Opsteegh, 2011, A quantitative microbial risk assessment from meatborne Toxoplasma gondii infection in The Netherlands, Int. J. Food Microbiol., 150, 103, 10.1016/j.ijfoodmicro.2011.07.022 Opsteegh, 2011, Low predictive value of seroprevalence of Toxoplasma gondii in cattle for detection of parasite DNA, Int. J. Parasitol., 41, 343, 10.1016/j.ijpara.2010.10.006 Opsteegh, 2015, Intervention strategies to reduce human toxoplasma gondii disease burden, Clin. Infect. Dis., 60, 101, 10.1093/cid/ciu721 Opsteegh, 2016, Relationship between seroprevalence in the main livestock species and presence of Toxoplasma gondii in meat. (GP/EFSA/BIOHAZ/2013/01) an extensive literature review, final report, EFSA Support. Publ., 13, 294 Øvernes, 1991, Immune response after immunization with an experimental Toxoplasma gondii ISCOM vaccine, Vaccine, 9, 25, 10.1016/0264-410X(91)90312-T Pena, 2008, Population structure and mouse-virulence of Toxoplasma gondii in Brazil, Int. J. Parasitol., 38, 561, 10.1016/j.ijpara.2007.09.004 Persson, 2007, Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii, J. Immunol., 179, 8357, 10.4049/jimmunol.179.12.8357 Pfefferkorn, 1984, Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan, Proc. Natl. Acad. Sci., 81, 908, 10.1073/pnas.81.3.908 Pinckney, 1994, Evaluation of the safety and efficacy of vaccination of nursing pigs with living tachyzoites of two strains of Toxoplasma gondii, J. Parasitol., 80, 438, 10.2307/3283415 Plattner, 2008, Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response, Cell Host Microbe, 3, 77, 10.1016/j.chom.2008.01.001 Pomares, 2011, Toxoplasmosis and horse meat, France, Emerg. Infect. Dis., 17, 1327, 10.3201/eid1707.101642 Remington, 1995, Toxoplasmosis, 140 Roach, 2005, The evolution of vertebrate Toll-like receptors, Proc. Natl. Acad. Sci., 102, 9577, 10.1073/pnas.0502272102 Robert-Gangneux, 2012, Epidemiology of and diagnostic strategies for toxoplasmosis, Clin. Microbiol. Rev., 25, 264, 10.1128/CMR.05013-11 Saraf, 2017, On the determination of Toxoplasma gondii virulence in mice, Exp. Parasitol., 174, 25, 10.1016/j.exppara.2017.01.009 Sasai, 2018, Host immune responses to Toxoplasma gondii, Int. Immunol., 30, 113, 10.1093/intimm/dxy004 Schlüter, 2014, Animals are key to human toxoplasmosis, Int. J. Med. Microbiol., 304, 917, 10.1016/j.ijmm.2014.09.002 Shen, 2014, Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9, MBio, 5, e01114, 10.1128/mBio.01114-14 Sher, 2017, Innate recognition of Toxoplasma gondii in humans involves a mechanism distinct from that utilized by rodents, Cell. Mol. Immunol., 14, 36, 10.1038/cmi.2016.12 Shwab, 2014, Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping, Parasitology, 141, 453, 10.1017/S0031182013001844 Shwab, 2016, The ROP18 and ROP5 gene allele types are highly predictive of virulence in mice across globally distributed strains of Toxoplasma gondii, Int. J. Parasitol., 46, 141, 10.1016/j.ijpara.2015.10.005 Sibley, 1992, Virulent strains of Toxoplasma gondii comprise a single clonal lineage, Nature, 359, 82, 10.1038/359082a0 Sidik, 2016, A genome-wide CRISPR screen in Toxoplasma identifies essential apicomplexan genes, Cell, 166, 1423, 10.1016/j.cell.2016.08.019 Sidik, 2018, CRISPR-Cas9-based genome-wide screening of Toxoplasma gondii, Nat. Protoc., 13, 307, 10.1038/nprot.2017.131 Slifko, 2000, Emerging parasite zoonoses associated with water and food, Int. J. Parasitol., 30, 1379, 10.1016/S0020-7519(00)00128-4 Splendore, 1908, vol. 3, 109 Stanley, 2004, Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep, Vaccine, 22, 3929, 10.1016/j.vaccine.2004.04.022 Su, 2012, Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages, Proc. Natl. Acad. Sci. U. S. A., 109, 5844, 10.1073/pnas.1203190109 Subauste, 2000, J. Immunol., 165, 1498, 10.4049/jimmunol.165.3.1498 Suijkerbuijk, 2018, The design of a social cost-benefit analysis of preventive interventions for toxoplasmosis: an example of the one health approach, Zoonoses Public Health, 65, 185, 10.1111/zph.12417 Suzuki, 1988, Interferon-gamma: the major mediator of resistance against Toxoplasma gondii, Science, 240, 516, 10.1126/science.3128869 Suzuki, 2011, Interferon-gamma-and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain, Expert Rev. Mol. Med., 13, 10.1017/S1462399411002018 Sykes, 2015, A game-theoretic approach to valuating toxoplasmosis vaccination strategies, vol. 105, 33 Szabo, 2017, Toxoplasma gondii: one organism, multiple models, Trends Parasitol., 33, 113, 10.1016/j.pt.2016.11.007 Tait, 2009, Advances in understanding immunity to Toxoplasma gondii, Mem. Inst. Oswaldo Cruz, 104, 201, 10.1590/S0074-02762009000200013 Tanaka, 2014, Vaccination with profilin encapsulated in oligomannose-coated liposomes induces significant protective immunity against Toxoplasma gondii, Vaccine, 32, 1781, 10.1016/j.vaccine.2014.01.095 Tombácz, 2018, Toxoplasma gondii profilin does not stimulate an innate immune response through bovine or human TLR5, Innate Immun., 24, 422, 10.1177/1753425918798450 Torgerson, 2013, The global burden of congenital toxoplasmosis: a systematic review, Bull. World Health Organ., 91, 501, 10.2471/BLT.12.111732 Torrey, 2013, Toxoplasma oocysts as a public health problem, Trends Parasitol., 29, 380, 10.1016/j.pt.2013.06.001 Tosh, 2016, The IL-12 response of primary human dendritic cells and monocytes to Toxoplasma gondii is stimulated by phagocytosis of live parasites rather than host cell invasion, J. Immunol., 196, 345, 10.4049/jimmunol.1501558 Uenishi, 2009, Porcine Toll-like receptors: the front line of pathogen monitoring and possible implications for disease resistance, Dev. Comp. Immunol., 33, 353, 10.1016/j.dci.2008.06.001 Uggla, 1988, Immunizing effects in mice of two Toxoplasma gondii iscom preparations, J. Veterinary Med. Ser. B, 35, 311, 10.1111/j.1439-0450.1988.tb00501.x Villena, 2010, Congenital toxoplasmosis in France in 2007: first results from a national surveillance system, Euro Surveill., 15 Wallon, 2018, Congenital toxoplasmosis: a plea for a neglected disease, Pathogens, 7, 25, 10.3390/pathogens7010025 Wang, 2013, Immunization with excreted-secreted antigens reduces tissue cyst formation in pigs, Parasitol. Res., 112, 3835, 10.1007/s00436-013-3571-4 Wang, 2017, Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis, Front. Microbiol., 8 Wilkins, 1987, Toxoplasmosis in sheep I. Effect of a killed vaccine on lambing losses caused by experimental challenge with Toxoplasma gondii, N. Z. Vet. J., 35, 31, 10.1080/00480169.1987.35371 Xiao, 2015, Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases, Acta Physiol (Oxford), 213, 828, 10.1111/apha.12458 Yarovinsky, 2014, Innate immunity to Toxoplasma gondii infection, Nat. Rev. Immunol., 14, 109, 10.1038/nri3598 Yarovinsky, 2005, TLR11 activation of dendritic cells by a protozoan profilin-like protein, Science, 308, 1626, 10.1126/science.1109893 Young, 2012, Recombinant protein expression and purification: a comprehensive review of affinity tags and microbial applications, Biotechnol. J., 7, 620, 10.1002/biot.201100155 Zhang, 2013, Vaccines against Toxoplasma gondii: New developments and perspectives, Expert Review of Vaccines, 12, 1287, 10.1586/14760584.2013.844652 Zulpo, 2012, Oocyst shedding in cats vaccinated by the nasal and rectal routes with crude rhoptry proteins of Toxoplasma gondii, Exp. Parasitol., 131, 223, 10.1016/j.exppara.2012.04.006 Zulpo, 2017, rROP2 from Toxoplasma gondii as a potential vaccine against oocyst shedding in domestic cats, Rev. Bras. Parasitol. Vet., 26, 67, 10.1590/s1984-29612017007 Zulpo, 2018, Toxoplasma gondii: a study of oocyst re-shedding in domestic cats, Vet. Parasitol., 249, 17, 10.1016/j.vetpar.2017.10.021